57 -3 (65) 2024 - M.H. Aliev, H.B. Orudzheva - THE STATE OF THE CARDIOVASCULAR SYSTEM IN PATIENTS WITH INFECTIOUS DISEASES

THE STATE OF THE CARDIOVASCULAR SYSTEM IN PATIENTS WITH INFECTIOUS DISEASES

M.H. Aliev Medical Center of the Ministry of Emergency Situations of the Republic of Azerbaijan, Baku

H.B. Orudzheva Medical Center of the Ministry of Emergency Situations of the Republic of Azerbaijan, Baku

Resume

Background. Long-term persistence in the body of infectious agents and viral pathogens, having a damaging effect on blood vessels, on cardiomyocytes, can lead to damage to heart tissues. The purpose of thse studies – to assess the state of the cardiovascular system in the most common infectious diseases. Materials and methods. The article uses data obtained on the detection of heart pathology among 325 patients aged 17 to 40 years and older. The nature of pathological cardiovascular changes in ENT diseases, SARS and rheumatism was revealed. A high incidence of cardiovascular pathology was established against the background of diseases associated with viral and bacterial infections. The severe nature of the course of infectious cardiopathology against the background of acute respiratory viral infections and rheumatism was noted. Conclusions. So, among those who were diagnosed with acute respiratory viral infections, patients with a pathology of the cardiovascular system of a mild form were more often detected - in 13.64%, against 4.08% and 6.25% in the first and second groups of subjects.

Keywords: infections, heart disease, diagnosis, prevalence

First page

302

Last page

307

For citation: M.H. Aliev, H.B. Orudzheva - THE STATE OF THE CARDIOVASCULAR SYSTEM IN PATIENTS WITH INFECTIOUS DISEASES//New Day in Medicine 3(65)2024 302-307 https://newdayworldmedicine.com/en/article/3758

List of References

  1. Антонова Т.В., Жевнерова Н.С. Вирусные миокардиты: этиология и патогенез, проблемы диагностики // Журнал инфектологии. 2013; 5(2):13-21.
  2. Керимова Г.А., Рустамова Л.И., Джаванширова Л.Б. и др. Наиболее распространенные инфекционные миокардиты: этиология, эпидемиология, клиника, диагностика и лечение // Вестник Казахского Национального медицинского университета, 2018; (3):15-18.
  3. Турсунова Н.Д., Шафигулина И.С., Гребенникова И.В., Черников С.Н. Патогенетические аспекты влияния COVID-19 на сердечно-сосудистую систему человека // European Journal of Natural History, 2022; 1:73-77.
  4. Abbasi J. The COVID Heart – One Year After SARS-CoV-2 Infection, Patients Have an Array of Increased Cardiovascular Risks // JAMA, 2022; 327(12):1113–1114.
  5. Almeida N., Queiroz M., Lima S. et al. Association of Chlamydia trachomatis, C. pneumoniae, and IL-6 and IL-8 Gene Alterations With Heart Diseases // Front. Immunol., 2019; 10:87.
  6. Behrouzi B., Bhatt D., Cannon C. et al. Association of Influenza Vaccination With Cardiovascular Risk: A Meta-analysis // JAMA Netw Open, 2022. 5(4):e228873.
  7. Cardiovascular diseases. World Health Organization. https://www.who.int/news-room/fact-sheets/detail/cardiovascular-diseases - (cvds). Published June 11, 2021. Accessed February 17, 2022.
  8. Coronary artery disease. Centers for Disease Control and Prevention. https://www.cdc.gov/heartdisease/coronary_ad.htm. Published July 19, 2021. Accessed February 17, 2022.
  9. Feng W., Zhang Z., Liu Y. et al. Association of Chronic Respiratory Symptoms With Incident Cardiovascular Disease and All-Cause Mortality: Findings From the Coronary Artery Risk Development in Young Adults Study // Chest., 2022. Apr. 161(4):1036-1045.
  10. Ghamri R., Alzahrani, N., Alharthi, A. et al. Cardiovascular risk factors among high-risk individuals attending the general practice at king Abdulaziz University hospital: a cross-sectional study // BMC Cardiovasc., 2019;19:268.
  11. Heart disease. Centers for Disease Control and Prevention. https://www.cdc.gov/nchs/fastats/heart-disease.htm. Published February 1, 2022. Accessed February 17, 2022.
  12. Jennifer A., Amitava B., Ian D. et al. Primary prevention of acute cardiovascular events by influenza vaccination: an observational study // European Heart Journal, 2023; 44(7/14):610–620.
  13. Khan M., Hashim M., Mustafa H. et al. (July 23, 2020) Global Epidemiology of Ischemic Heart Disease: Results from the Global Burden of Disease Study // Cureus., 2020; 12(7):9349.
  14. Leone O., Pieroni M., Rapezzi C. et al. The spectrum of myocarditis: from pathology to the clinics // Virchows Arch., 2019; 475:279–301.
  15. Mayo-Yáñez M., González-Torres L. Recurrent Penicillin-Resistant Tonsillitis Due to Lactococcus garvieae, a New Zoonosis from Aquaculture // Zoonotic Dis., 2023; 3:1–5.
  16. Mezhal F., Oulha, A., Abdulle A. et al. High prevalence of cardiometabolic risk factors amongst young adults in the United Arab Emirates: the UAE Healthy Future Study // BMC Cardiovasc. Disord., 2023; 23:137.
  17. Norhammar A., Bodegard J., Vanderheyden M. et al. Prevalence, outcomes and costs of a contemporary, multinational population with heart failure // Heart., 2023; 109:548–556.
  18. Sahin M., Yalcin M., Kocyigit D. Prevalence of rheumatic heart disease in patients with recurrent tonsillitis and elevated anti-streptolysin O titers // Int. J. Pediatr. Otorhinolaryngol., 2016; 89:133-135.
  19. Stickel A., Tarraf W., Bainbridge K. et al. Hearing Sensitivity, Cardiovascular Risk, and Neurocognitive Function: The Hispanic Community Health Study/Study of Latinos (HCHS/SOL) // JAMA Otolaryngol Head Neck Surg. 2021; 147(4):377–387.
  20. Tsao C., Aday A., Almarzooq Z. et al. American Heart Association Council on Epidemiology and Prevention Statistics Committee and Stroke Statistics Subcommittee. Heart Disease and Stroke Statistics-2023 Update: A Report From the American Heart Association // Circulation. 2023; 21/147(8):93-621.

    file

    download